Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancer

Abstract Background Although the addition of neoadjuvant immune checkpoint blockade to chemotherapy has improved patient outcome in early triple‑negative breast cancer (TNBC), some patients continue to have poor disease outcomes. Methods To characterise neoadjuvant chemotherapy (NAC) resistant cell...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yu Zhang, Fatemeh Ahmadi Moughari, Ioanna Mavrommati, Nora J. Doleschall, Kate Moore, Gareth Muirhead, Ram Rajaram Srinivasan, Ping Gong, Jonathan T. Lei, Amy Fleming, Hwei Minn Khoo, Naomi Guppy, Gabrielle Elshtein, Mohammed Inayatullah, Vijay K. Tiwari, Lacey E. Dobrolecki, Michael T. Lewis, Syed Haider, Rachael Natrajan
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2026-04-01
סדרה:	Genome Medicine
נושאים:	Triple-negative breast cancer Residual disease Neoadjuvant chemotherapy resistance Drug-tolerant persister cells KDM5B Hypoxia
גישה מקוונת:	https://doi.org/10.1186/s13073-026-01643-9
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!